Research

Cellular

Grip strength declined by 38% following semaglutide treatment.

Monitoring grip strength may be important in patients receiving GLP-1RA therapy to assess muscle function.

StrongRefutesmedium confidence
Grip strength declined by 38% following semaglutide treatment.
Eric B. Emanuelsson et al. · The Journal of Physiology · 2025

Why this rating

The claim is based on direct measurements reported in the abstract.

Source

Body composition matters: Preserving muscle and function in the era of GLP‐1‐based weight loss therapies

Eric B. Emanuelsson et al. · The Journal of Physiology · 2025

DOI 10.1113/jp290350

other
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →